{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T14:13:07Z","timestamp":1769523187695,"version":"3.49.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["CURR MED SCI"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1007\/s11596-018-1861-x","type":"journal-article","created":{"date-parts":[[2018,3,15]],"date-time":"2018-03-15T06:21:02Z","timestamp":1521094862000},"page":"167-173","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Pharmacokinetic Characteristics of Baicalin in Rats with 17\u03b1-ethynyl-estradiol-induced Intrahepatic Cholestasis"],"prefix":"10.1007","volume":"38","author":[{"given":"Cheng-liang","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan-jiao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dong","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin-yu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kai","family":"Lei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,3,15]]},"reference":[{"issue":"1","key":"1861_CR1","doi-asserted-by":"publisher","first-page":"G1","DOI":"10.1152\/ajpgi.00028.2017","volume":"313","author":"V Pataia","year":"2017","unstructured":"Pataia V, Dixon PH, Williamson C. Pregnancy and bile acid disorders. Am J Physiol Gastrointest Liver Physiol, 2017,313(1): G1\u2013G6","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"1","key":"1861_CR2","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/S1089-3261(03)00131-4","volume":"8","author":"CA Riely","year":"2004","unstructured":"Riely CA, Bacq Y. Intrahepatic cholestasis of pregnancy. Clin Liver Dis, 2004, 8(1): 167\u2013176","journal-title":"Clin Liver Dis"},{"issue":"6","key":"1861_CR3","doi-asserted-by":"publisher","first-page":"1993","DOI":"10.1002\/hep.27171","volume":"60","author":"X Song","year":"2014","unstructured":"Song X, Vasilenko A, Chen Y, et al. Transcriptional dynamics of bile salt export pump during pregnancy: mechanisms and implications in intrahepatic cholestasis of pregnancy. Hepatology, 2014, 60(6): 1993\u20132007","journal-title":"Hepatology"},{"issue":"9714","key":"1861_CR4","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1016\/S0140-6736(09)61495-1","volume":"375","author":"D Joshi","year":"2010","unstructured":"Joshi D, James A, Quaglia A, et al. Liver disease in pregnancy. Lancet, 2010, 375(9714): 594\u2013605","journal-title":"Lancet"},{"issue":"10","key":"1861_CR5","doi-asserted-by":"publisher","first-page":"2231","DOI":"10.1007\/s10620-008-0600-8","volume":"54","author":"MA Kotb","year":"2009","unstructured":"Kotb MA. Ursodeoxycholic acid in neonatal hepatitis and infantile paucity of intrahepatic bile ducts: review of a historical cohort. Dig Dis Sci, 2009, 54(10): 2231\u20132241","journal-title":"Dig Dis Sci"},{"issue":"1","key":"1861_CR6","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1142\/S0192415X96000050","volume":"24","author":"CC Lin","year":"1996","unstructured":"Lin CC, Shieh DE. The anti-inflammatory activity of Scutellaria rivularis extracts and its active components, baicalin, baicalein and wogonin. Am J Chin Med, 1996,24(1): 31\u201336","journal-title":"Am J Chin Med"},{"issue":"1","key":"1861_CR7","doi-asserted-by":"publisher","first-page":"16","DOI":"10.3109\/09553002.2012.717733","volume":"89","author":"S Rockwell","year":"2013","unstructured":"Rockwell S, Grove TA, Liu Y, et al. Preclinical studies of the Chinese Herbal Medicine formulation PHY906 (KD018) as a potential adjunct to radiation therapy. Int J Radiat Biol, 2013, 89(1): 16\u201325","journal-title":"Int J Radiat Biol"},{"issue":"8","key":"1861_CR8","first-page":"1418","volume":"33","author":"FJ Sun","year":"2011","unstructured":"Sun FJ, Chen HH, Wang CF, et al. Study on the cholaneresis of Chaihu and Huangqin. Zhong Cheng Yao (Chinese), 2011, 33(8): 1418\u20131420","journal-title":"Zhong Cheng Yao (Chinese)"},{"key":"1861_CR9","first-page":"301","volume":"1","author":"Chinese Pharmacopoeia Commission.","year":"2015","unstructured":"Chinese Pharmacopoeia Commission. Chinese Pharmacopoeia of 2015 Edition. Beijing: The Medicine Science and Technology Press of China, 2015, 1:301\u2013302","journal-title":"Beijing: The Medicine Science and Technology Press of China"},{"key":"1861_CR10","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.ejmech.2017.03.004","volume":"131","author":"B Dinda","year":"2017","unstructured":"Dinda B, Dinda S, DasSharma S, et al. Therapeutic potentials of baicalin and its aglycone, baicalein against inflammatory disorders. Eur J Med Chem, 2017, 131:68\u201380","journal-title":"Eur J Med Chem"},{"key":"1861_CR11","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.ejphar.2012.01.010","volume":"680","author":"Y Zhang","year":"2012","unstructured":"Zhang Y, Huang Y, Deng X, et al. Iron overload-induced rat liver injury: Involvement of protein tyrosine nitration and the effect of baicalin. Eur J Pharmacol, 2012,680(l-3): 95\u2013101","journal-title":"Eur J Pharmacol"},{"issue":"4","key":"1861_CR12","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1111\/j.1478-3231.2007.01450.x","volume":"27","author":"LL Liu","year":"2007","unstructured":"Liu LL, Gong LK, Wang H, et al. Baicalin protects mouse from Concanavalin A-induced liver injury through inhibition of cytokine production and hepatocyte apoptosis. Liver Int, 2007, 27(4): 582\u2013591","journal-title":"Liver Int"},{"issue":"10","key":"1861_CR13","doi-asserted-by":"publisher","first-page":"901","DOI":"10.3109\/00498254.2013.783250","volume":"43","author":"YH Choi","year":"2013","unstructured":"Choi YH, Lee YK, Lee MG. Effects of 17alpha-ethynylestradiol-induced cholestasis on the pharmacokinetics of doxorubicin in rats: reduced biliary excretion and hepatic metabolism of doxorubicin. Xenobiotica, 2013, 43(10): 901\u2013907","journal-title":"Xenobiotica"},{"issue":"4","key":"1861_CR14","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1007\/BF02968578","volume":"29","author":"SS Hong","year":"2006","unstructured":"Hong SS, Choi JM, Jin HE, et al. Altered pharmacokinetics and hepatic uptake of TBuMA in ethynylestradiol-induced cholestasis. Arch Pharm Res, 2006, 29(4): 323\u2013327","journal-title":"Arch Pharm Res"},{"issue":"1","key":"1861_CR15","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/sj.bjp.0706148","volume":"145","author":"DY Hung","year":"2005","unstructured":"Hung DY, Siebert GA, Chang P, et al. Hepatic pharmacokinetics of taurocholate in the normal and cholestatic rat liver. Br J Pharmacol, 2005, 145(1): 57\u201365","journal-title":"Br J Pharmacol"},{"issue":"3","key":"1861_CR16","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1177\/002215549804600315","volume":"46","author":"L Landmann","year":"1998","unstructured":"Landmann L, Angermuller S, Rahner C, et al. Expression, distribution, and activity of Na+,K+-ATPase in normal and cholestatic rat liver. J Histochem Cytochem, 1998, 46(3): 405\u2013410","journal-title":"J Histochem Cytochem"},{"issue":"24","key":"1861_CR17","doi-asserted-by":"publisher","first-page":"16625","DOI":"10.1074\/jbc.M602723200","volume":"281","author":"Y Yamamoto","year":"2006","unstructured":"Yamamoto Y, Moore R, Hess HA, et al. Estrogen receptor alpha mediates 17alpha-ethynylestradiol causing hepatotoxicity. J Biol Chem, 2006, 281(24): 16625\u201316631","journal-title":"J Biol Chem"},{"issue":"6","key":"1861_CR18","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1124\/dmd.106.009308","volume":"34","author":"FA Crocenzi","year":"2006","unstructured":"Crocenzi FA, Pellegrino JM, Catania VA, et al. Galactosamine prevents ethinylestradiol-induced cholestasis. Drug Metab Dispos, 2006, 34(6): 993\u2013997","journal-title":"Drug Metab Dispos"},{"issue":"2","key":"1861_CR19","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1053\/jhep.2001.26520","volume":"34","author":"F S Crocenzi","year":"2001","unstructured":"Crocenzi FA, Sanchez Pozzi EJ, Pellegrino JM, et al. Beneficial effects of Silymarin on estrogen-induced cholestasis in the rat: a study in vivo and in isolated hepatocyte couplets. Hepatology, 2001,34 (2): 329\u2013339","journal-title":"Hepatology"},{"issue":"4","key":"1861_CR20","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/S1665-2681(19)32126-X","volume":"2","author":"EA Rodriguez-Garay","year":"2003","unstructured":"Rodriguez-Garay EA. Cholestasis: human disease and experimental animal models. Ann Hepatol, 2003, 2(4): 150\u2013158","journal-title":"Ann Hepatol"},{"issue":"l-2","key":"1861_CR21","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.lfs.2014.07.024","volume":"113","author":"D Liu","year":"2014","unstructured":"Liu D, Wu T, Zhang CL, et al. Beneficial effect of Calculus Bovis Sativus on 17alpha-ethynylestradiol-induced cholestasis in the rat. Life Sei, 2014,113 (l-2): 22\u201330","journal-title":"Life Sei"},{"issue":"8","key":"1861_CR22","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1002\/bdd.771","volume":"32","author":"C Li","year":"2011","unstructured":"Li C, Lin G, Zuo Z. Pharmacological effects and pharmacokinetics properties of Radix Scutellariae and its bioactive flavones. Biopharm Drug Dispos, 2011,32 (8): 427\u2013445","journal-title":"Biopharm Drug Dispos"},{"issue":"37","key":"1861_CR23","doi-asserted-by":"publisher","first-page":"4720","DOI":"10.3748\/wjg.15.4720","volume":"15","author":"XD Peng","year":"2009","unstructured":"Peng XD, Dai LL, Huang CQ, et al. Correlation between anti-fibrotic effect of baicalin and serum cytokines in rat hepatic fibrosis. World J Gastroenterol, 2009,15 (37): 4720\u20134725","journal-title":"World J Gastroenterol"},{"key":"1861_CR24","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.phrs.2015.08.021","volume":"100","author":"MR Oliveira de","year":"2015","unstructured":"de Oliveira MR, Nabavi SF, Habtemariam S, et al. The effects of baicalein and baicalin on mitochondrial function and dynamics: A review. Pharmacol Res, 2015, 100:296\u2013308","journal-title":"Pharmacol Res"},{"issue":"3","key":"1861_CR25","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1016\/j.jep.2006.09.036","volume":"110","author":"T Lu","year":"2007","unstructured":"Lu T, Song J, Huang F, et al. Comparative pharmacokinetics of baicalin after oral administration of pure baicalin, Radix Scutellariae extract and-Huang-Lian-Jie-Du-Tang to rats. J Ethnopharmacol, 2007, 110(3): 412\u2013418","journal-title":"J Ethnopharmacol"},{"issue":"2","key":"1861_CR26","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1007\/BF02977703","volume":"30","author":"YH Kim","year":"2007","unstructured":"Kim YH, Jeong DW, Kim YC, et al. Pharmacokinetics of baicalein, baicalin and wogonin after oral administration of a standardized extract of Scutellaria baicalensis, PF-2405 in rats. Arch Pharm Res, 2007, 30(2): 260\u2013265 173","journal-title":"Arch Pharm Res"},{"issue":"3","key":"1861_CR27","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1007\/s12272-013-0179-2","volume":"37","author":"MJ Kang","year":"2014","unstructured":"Kang MJ, Ko GS, Oh DG, et al. Role of metabolism by intestinal microbiota in pharmacokinetics of oral baicalin. Arch Pharm Res, 2014, 37(3): 371\u2013378","journal-title":"Arch Pharm Res"},{"issue":"9","key":"1861_CR28","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1111\/j.1440-1746.2005.03950.x","volume":"20","author":"T Kamisako","year":"2005","unstructured":"Kamisako T, Ogawa H. Alteration of the expression of adenosine triphosphate-binding cassette transporters associated with bile acid and cholesterol transport in the rat liver and intestine during cholestasis. J Gastroenterol Hepatol, 2005, 20(9): 1429\u20131434","journal-title":"J Gastroenterol Hepatol"},{"issue":"2","key":"1861_CR29","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1097\/00005176-200208000-00015","volume":"35","author":"D Micheline","year":"2002","unstructured":"Micheline D, Emmanuel J, Serge E. Effect of Ursodeoxycholic Acid on the Expression of the Hepatocellular Bile Acid Transporters (Ntcp and bsep) in Rats With Estrogen-Induced Cholestasis. J Pediatr Gastroenterol Nutr, 2002, 35(2): 185\u2013191","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"11","key":"1861_CR30","doi-asserted-by":"publisher","first-page":"2060","DOI":"10.1124\/dmd.107.016519","volume":"35","author":"ML Ruiz","year":"2007","unstructured":"Ruiz ML, Villanueva SS, Luquita MG, et al. Beneficial effect of spironolactone administration on ethynylestradiol-induced cholestasis in the rat: involvement of up-regulation of multidrug resistance-associated protein 2. Drug Metab Dispos, 2007, 35(11): 2060\u20132066","journal-title":"Drug Metab Dispos"},{"issue":"7","key":"1861_CR31","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1124\/dmd.104.003533","volume":"33","author":"FA Crocenzi","year":"2005","unstructured":"Crocenzi FA, D'Andrea V, Catania VA, et al. Prevention of Mrp2 activity impairment in ethinylestradiol-induced cholestasis by ursodeoxycholate in the rat. Drug Metab Dispos, 2005, 33(7): 888\u2013891","journal-title":"Drug Metab Dispos"},{"key":"1861_CR32","doi-asserted-by":"crossref","first-page":"1640187","DOI":"10.1155\/2017\/1640187","volume":"2017","author":"D Xiang","year":"2017","unstructured":"Xiang D, Wu T, Feng CY, et al. Upregulation of PDZK1 by Calculus Bovis Sativus May Play an Important Role in Restoring Biliary Transport Function in Intrahepatic Cholestasis. Evid Based Complement Alternat Med, 2017,2017:1640187","journal-title":"Evid Based Complement Alternat Med"},{"issue":"1","key":"1861_CR33","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1211\/jpp.59.1.0012","volume":"59","author":"T Akao","year":"2007","unstructured":"Akao T, Hanada M, Sakashita Y, et al. Efflux of baicalin, a flavone glucuronide of Scutellariae Radix, on Caco-2 cells through multidrug resistance-associated protein 2. J Pharm Pharmacol, 2007,59(1): 87\u201393","journal-title":"J Pharm Pharmacol"},{"issue":"3","key":"1861_CR34","first-page":"399","volume":"12","author":"ZQ Zhang","year":"2013","unstructured":"Zhang ZQ, Liua W, Zhuang L, et al. Comparative pharmacokinetics of baicalin, wogonoside, baicalein and wogonin in plasma after oral administration of pure baicalin, radix Scutellariae and scutellariae-paeoniae couple extracts in normal and ulcerative colitis rats. Iran J Pharm Res, 2013, 12(3): 399\u2013409","journal-title":"Iran J Pharm Res"},{"issue":"11","key":"1861_CR35","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1111\/1751-2980.12407","volume":"17","author":"M J Chang","year":"2016","unstructured":"Chang M J, Xu YJ, He WX, et al. Intestinal injury in the rat model of 17alpha-ethynylestradiol-induced intrahepatic cholestasis. J Dig Dis, 2016, 17(11): 756\u2013763","journal-title":"J Dig Dis"},{"issue":"4","key":"1861_CR36","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1177\/1756283X13482996","volume":"6","author":"CM Guinane","year":"2013","unstructured":"Guinane CM, Cotter PD. Role of the gut microbiota in health and chronic gastrointestinal disease: understanding a hidden metabolic organ. Therap Adv Gastroenterol, 2013, 6(4): 295\u2013308","journal-title":"Therap Adv Gastroenterol"},{"issue":"10","key":"1861_CR37","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1517\/17425255.2013.807798","volume":"9","author":"MJ Kang","year":"2013","unstructured":"Kang MJ, Kim HG, Kim JS, et al. The effect of gut microbiota on drug metabolism. Expert Opin Drug Metab Toxicol, 2013, 9(10): 1295\u20131308","journal-title":"Expert Opin Drug Metab Toxicol"},{"issue":"8","key":"1861_CR38","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1016\/j.fitote.2012.08.007","volume":"83","author":"YX Deng","year":"2012","unstructured":"Deng YX, Shi QZ, Chen B, et al. Comparative pharmacokinetics of baicalin in normal and the type2 diabetic rats after oral administration of the Radix Scutellariae extract. Fitoterapia, 2012, 83(8): 1435\u20131442","journal-title":"Fitoterapia"},{"issue":"3","key":"1861_CR39","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1111\/j.1365-2362.2006.01616.x","volume":"36","author":"SF Assimakopoulos","year":"2006","unstructured":"Assimakopoulos SF, Thomopoulos KC, Patsoukis N, et al. Evidence for intestinal oxidative stress in patients with obstructive jaundice. Eur J Clin Invest, 2006,36 (3): 181\u2013187","journal-title":"Eur J Clin Invest"},{"issue":"2","key":"1861_CR40","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1046\/j.0001-6772.2003.01229.x","volume":"180","author":"SF Assimakopoulos","year":"2004","unstructured":"Assimakopoulos SF, Vagianos CE, Patsoukis N, et al. Evidence for intestinal oxidative stress in obstructive jaundice-induced gut barrier dysfunction in rats. Acta Physiol Scand, 2004, 180(2): 177\u2013185","journal-title":"Acta Physiol Scand"}],"container-title":["Current Medical Science"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11596-018-1861-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11596-018-1861-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11596-018-1861-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T20:16:41Z","timestamp":1751487401000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11596-018-1861-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,2]]}},"alternative-id":["1861"],"URL":"https:\/\/doi.org\/10.1007\/s11596-018-1861-x","relation":{},"ISSN":["2096-5230","2523-899X"],"issn-type":[{"value":"2096-5230","type":"print"},{"value":"2523-899X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2]]},"assertion":[{"value":"20 May 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 November 2017","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 March 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}